Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013


Payer Strategies for Emerging Markets

30 Jul 2013 - 01 Aug 2013 - Philadelphia, PA, USA



Bookmark and Share


Emerging markets are moving up the agenda of pharma and global healthcare organizations. Yet many regions are still unchartered territory and are difficult to navigate. To build effective strategic partnerships and drive the most profitable performance, you need to understand the dynamics that make these regions so challenging, yet full of potential...

That means the payers. What they need.  How they need it.  When they need it.

Payer Strategies for Emerging Markets will set you up to execute the most successful product launches in the world’s key growth markets.  Learn to manage the transformation of your traditional pharmaceutical business model to one that really takes hold in the world’s key growth economies.

This meeting will provide you with the clarity you need to demonstrate maximum product value to payers in emerging markets. The agenda has been designed in collaboration with leaders from organizations like Pfizer, Abbott, World Bank, Novartis, Merck and the World Health Organization.

Build solid payer-industry partnerships at this highly interactive forum. Payer Strategies for Emerging Markets was created for you to meet the key stakeholders who can give you the gold standard business intelligence to adapt your market access approach in different regions.

Meet pharma, payer organizations and key solution providers. This meeting lets you use these relationships to refine your product launch strategy and strengthen the foundation for commercial success in emerging markets.

At the meeting you will…

Gain an insight into regional price containment strategies. Avoid the hurdles to maximize impact at product launch

Ensure maximum patient compliance.  Find out how to best engage with an out of pocket payer in a changing health economic environment

Keep early value demonstration front of mind when preparing healthcare authorities for your product hitting the market

Develop actionable pricing and reimbursement strategies for streamlined access in emerging markets

Adapt your marketing approach and design your distribution strategies to meet the needs of both the public and private payer for long-term, regional, profitable success

Discover the benefits of local and corporate team integration to avoid a culture clash when accessing emerging markets

Understand the importance of a clear launch strategy for optimal product development and distribution in emerging markets

Payer Strategies for Emerging Markets will equip you with the knowledge and tools to boost business in key growth economies.  Get an understanding of the payers and develop unique strategies to adapt and optimize your access approach in emerging markets.

Who you’ll meet…

Pharmaceutical Companies: Heads of Marketing, Pricing, Reimbursement, Medical Affairs and Market Access looking to partner with payers and plan developers to optimize reimbursement and build strategic relationships

Payers and Plan Developers: Group Directors and Managers looking to gain a more thorough understanding of the access and pricing environment and form strategic partnerships with pharma

Market Access Consultancies: Vice President of Sales and Marketing and Directors of Business Development keen to generate new business, successfully collaborate with industry leaders and stay front-of-mind when pharma look to source consultants




Further information
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!